Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.6K
Explicit Memories01:27

Explicit Memories

453
Explicit memories, also known as declarative memories, are consciously remembered, recalled, and reported. Studying for a chemistry exam involves material that will become part of explicit memory. There are two types of explicit memory: episodic and semantic.
Episodic memory contains information about personally experienced events and is reported as a story. An example of episodic memory is recalling a birthday celebration. This type of memory includes the what, where, and when of an event, as...
453
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

442
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
442
Facilitated Transport01:19

Facilitated Transport

148.1K
The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
148.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.5K
Social Facilitation01:04

Social Facilitation

36.6K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
36.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical Impact Assessment of Sharing Nanosafety Data.

Open research Europe·2026
Same author

Outcomes and future activities of the 'Pan-European network in Lipidomics and EpiLipidomics - EpiLipidNET'.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

Mapping spatially organized molecular and genetic signatures of schizophrenia across multiple scales in human prefrontal cortex.

bioRxiv : the preprint server for biology·2026
Same author

Fostering and sustaining collaborative innovation: Insights from ELIXIR Europe's life science Communities.

F1000Research·2025
Same author

<i>APOE</i> E4 Alzheimer's Risk Converges on an Oligodendrocyte Subtype in the Human Entorhinal Cortex.

bioRxiv : the preprint server for biology·2025
Same author

Impact of Alzheimer's disease risk factors and local neuromelanin content on the transcriptomic landscape of the human locus coeruleus.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Feb 2, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

Explicit interaction information from WikiPathways in RDF facilitates drug discovery in the Open PHACTS Discovery

Ryan A Miller1, Peter Woollard2, Egon L Willighagen1

  • 1Department of Bioinformatics (BiGCaT), Maastricht University, Maastricht, The Netherlands.

F1000Research
|November 15, 2018
PubMed
Summary

The Open PHACTS Discovery Platform now integrates updated WikiPathways data, enhancing its biological interaction information. This upgrade supports answering complex pathway-related scientific questions within the pharmaceutical industry.

Keywords:
APIOpen PHACTSWikiPathwaysbioinformaticsdrug discoverypathway databasesemantic

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

10.4K

Related Experiment Videos

Last Updated: Feb 2, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

10.4K

Area of Science:

  • Pharmacology
  • Bioinformatics
  • Systems Biology

Background:

  • The pharmaceutical industry requires high-quality biological interaction data to address complex scientific questions.
  • The Open PHACTS Discovery Platform aims to provide such data for drug discovery and development.
  • Existing data lacked comprehensive information on biological interactions like stimulation and inhibition.

Purpose of the Study:

  • To enhance the Open PHACTS Discovery Platform with updated biological interaction data.
  • To improve the platform's capability in answering pathway-related scientific questions.
  • To make this enhanced data accessible via the platform's API.

Main Methods:

  • Integrated updated WikiPathways data into the Open PHACTS Discovery Platform.
  • Included detailed information on biological interactions, including stimulation and inhibition.
  • Extended the Open PHACTS Application Programming Interface (API) with new methods to access interaction data.

Main Results:

  • The Open PHACTS Discovery Platform now contains enriched biological interaction data.
  • The platform's ability to answer pathway-related questions is significantly improved.
  • New API methods for accessing interaction data are publicly available.

Conclusions:

  • The integration of WikiPathways data enhances the Open PHACTS Discovery Platform's utility.
  • This advancement supports pharmaceutical research by providing critical biological interaction insights.
  • The updated API facilitates easier access to crucial pathway information for researchers.